However, I do think they have had adequate time and capital to consider providing compassionate use or expand the Ph2 protocol. Been almost 2 years since the Ph2 results and not a single additional patient has been treated.
One behavior that is suspect to me is SRPT's lack of forthrightness about the timing of the FDA meetings and the use of ATMs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.